Camilla Huse

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI Trial.

Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI Trial.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: April 23, 2026

Role of Interleukin-6 in Atherothrombosis and Myocardial Infarction.

Role of Interleukin-6 in Atherothrombosis and Myocardial Infarction.

Journal: Current atherosclerosis reports

Published: August 21, 2025

The effects of interleukin-6-receptor inhibition on monocytes in STEMI: a substudy of the ASSAIL-MI trial.

The effects of interleukin-6-receptor inhibition on monocytes in STEMI: a substudy of the ASSAIL-MI trial.

Journal: EBioMedicine

Published: May 23, 2025

The N-6 methyladenosine dynamics in STEMI and the effect of IL-6 inhibition - a hypothesis generating sub-study of the ASSAIL-MI trial.

The N-6 methyladenosine dynamics in STEMI and the effect of IL-6 inhibition - a hypothesis generating sub-study of the ASSAIL-MI trial.

Journal: Frontiers in immunology

Published: November 21, 2024

Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial Infarction.

Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial Infarction.

Journal: International journal of molecular sciences

Published: June 20, 2024

Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI.

Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI.

Journal: International journal of cardiology

Published: May 30, 2024

Testosterone exacerbates neutrophilia and cardiac injury in myocardial infarction via actions in bone marrow.

Testosterone exacerbates neutrophilia and cardiac injury in myocardial infarction via actions in bone marrow.

Journal: Nature communications

Published: March 14, 2024

Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct Size.

Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct Size.

Journal: JACC. Advances

Published: March 10, 2024

Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study.

Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study.

Journal: Frontiers in immunology

Published: January 31, 2024

Circulating markers of extracellular matrix remodelling in severe COVID-19 patients.

Circulating markers of extracellular matrix remodelling in severe COVID-19 patients.

Journal: Journal of internal medicine

Published: September 18, 2023

Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab.

Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab.

Journal: Open heart

Published: March 18, 2023

Severely ill COVID-19 patients have altered circulating levels of proteins controlling the epitranscriptome.

Severely ill COVID-19 patients have altered circulating levels of proteins controlling the epitranscriptome.

Journal: The Journal of infection

Published: February 28, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026